Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

18.222.35.177
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Journal Scan
Lupus Nephritis

Nearly one-third of men with SLE develop serositis

Posted on

Male gender and CrithidiaDNA+ are risk factors for serositis in patients with systemic lupus erythematosus (SLE), according to a study.

-Advertisement-
-Advertisement-

Serositis is associated with high morbidity and its prevalence is between approximately 11% and 54%.

In this retrospective case-control study of 297 patients with SLE, the overall prevalence of serositis was 9.42%; this was the first manifestation in 40.7%. Prevalence was 30% in men and 7.9% in women.

Patients with serositis received more corticosteroid pulses and higher maximum doses compared to other severe manifestations seen in SLE, “which could imply a more aggressive form of SLE in patients with serositis,” the authors wrote.

Reference
Gimeno-Torres L, Carrión-Barberà I, Durán X, et al. Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study. Lupus. 2021;doi: 10.1177/09612033211049305. Epub ahead of print. PMID: 34794346.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-